Compare RLAY & VRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RLAY | VRTS |
|---|---|---|
| Founded | 2015 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2020 | 1992 |
| Metric | RLAY | VRTS |
|---|---|---|
| Price | $8.66 | $164.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | $16.00 | ★ $179.60 |
| AVG Volume (30 Days) | ★ 2.3M | 80.5K |
| Earning Date | 11-06-2025 | 01-30-2026 |
| Dividend Yield | N/A | ★ 5.94% |
| EPS Growth | N/A | ★ 18.44 |
| EPS | N/A | ★ 19.47 |
| Revenue | $8,355,000.00 | ★ $878,336,000.00 |
| Revenue This Year | $20.47 | N/A |
| Revenue Next Year | N/A | $0.15 |
| P/E Ratio | ★ N/A | $8.30 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.78 | $142.18 |
| 52 Week High | $9.04 | $227.38 |
| Indicator | RLAY | VRTS |
|---|---|---|
| Relative Strength Index (RSI) | 66.58 | 52.37 |
| Support Level | $7.95 | $160.39 |
| Resistance Level | $9.04 | $168.25 |
| Average True Range (ATR) | 0.50 | 4.88 |
| MACD | 0.04 | 0.59 |
| Stochastic Oscillator | 77.78 | 61.63 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.